Healthcare

NeuroBlu: New Data Partner and Enterprise SSO Integration

Major expansion of behavioral health data with 940K+ new patient records, enterprise SSO integration, and enhanced analytics tools for deeper…

2 months ago

CHOP, University of Pittsburgh Researchers Demonstrate Modified Health Questionnaire is Better at Predicting Suicidal Behavior Among Teens

Three questions on modified health questionnaire were more likely to predict suicidal behavior within one year of screening PHILADELPHIA, Nov.…

2 months ago

Medely Partners with Oracle to Revolutionize Healthcare Staffing through Oracle Healthcare Talent Network

LOS ANGELES, Oct. 31, 2024 /PRNewswire/ -- Medely, a leader in workforce management solutions, announces its integration with the Oracle…

2 months ago

miraDry® Celebrates Hyperhidrosis Awareness Month and Hosts Global Virtual Event for Patients and Providers

NEWPORT BEACH, Calif., Nov. 1, 2024 /PRNewswire/ -- miraDry, Inc., a leader in excessive underarm sweat treatment, proudly celebrates Hyperhidrosis…

2 months ago

Get Well Appoints Thomas Elbert as Chief Operating Officer

Executive brings more than 20 years of healthcare information technology, data architecture, and analytics experience BETHESDA, Md., Nov. 1, 2024…

2 months ago

UnisLink Earns HITRUST I1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

HITRUST certification validates that UnisLink is operating with leading security practices to protect sensitive information.PHOENIX, AZ / ACCESSWIRE / November…

2 months ago

RTI Surgical Completes Acquisition of Collagen Solutions

RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a…

2 months ago

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary…

2 months ago

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both liver fibrosis and MASH resolution in the ESSENCE trial

Bagsværd, Denmark, 1 November 2024 – Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE…

2 months ago